These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31322990)

  • 61. Patient characteristics associated with favorable perceptions of patient-provider communication in early-stage lung cancer treatment.
    Dalton AF; Bunton AJ; Cykert S; Corbie-Smith G; Dilworth-Anderson P; McGuire FR; Monroe MH; Walker P; Edwards LJ
    J Health Commun; 2014; 19(5):532-44. PubMed ID: 24359327
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).
    Lam VK; Bentzen SM; Mohindra P; Nichols EM; Bhooshan N; Vyfhuis M; Scilla KA; Feigenberg SJ; Edelman MJ; Feliciano JL
    Lung Cancer; 2017 Feb; 104():52-57. PubMed ID: 28213000
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set.
    Griffith SD; Miksad RA; Calkins G; You P; Lipitz NG; Bourla AB; Williams E; George DJ; Schrag D; Khozin S; Capra WB; Taylor MD; Abernethy AP
    JCO Clin Cancer Inform; 2019 Aug; 3():1-13. PubMed ID: 31403818
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Defining the Elements of Early Palliative Care That Are Associated With Patient-Reported Outcomes and the Delivery of End-of-Life Care.
    Hoerger M; Greer JA; Jackson VA; Park ER; Pirl WF; El-Jawahri A; Gallagher ER; Hagan T; Jacobsen J; Perry LM; Temel JS
    J Clin Oncol; 2018 Apr; 36(11):1096-1102. PubMed ID: 29474102
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy.
    Lee H; Jin GY; Han YM; Chung GH; Lee YC; Kwon KS; Lynch D
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):343-50. PubMed ID: 21626257
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade.
    Sung MR; Patel MV; Djalalov S; Le LW; Shepherd FA; Burkes RL; Feld R; Lin S; Tudor R; Leighl NB
    Clin Lung Cancer; 2017 May; 18(3):274-280.e6. PubMed ID: 28185791
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
    Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
    Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patients' Perceptions at Diagnosis: Lung Cancer Discovery and Provider Relationships.
    Somayaji D; Mohedat H; Dean GE; Dickerson SS
    Cancer Nurs; 2022 Sep-Oct 01; 45(5):397-405. PubMed ID: 35067577
    [TBL] [Abstract][Full Text] [Related]  

  • 71. What is the Definition of Cure in Non-small Cell Lung Cancer?
    Morgan H; Ellis L; O'Dowd EL; Murray RL; Hubbard R; Baldwin DR
    Oncol Ther; 2021 Dec; 9(2):365-371. PubMed ID: 34374957
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patient Perspectives in Cancer Surgery.
    Martin D; Demartines N; Hübner M
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160241
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Time of day shapes the success of a cancer treatment.
    Gabriel CH; Kramer A
    Nature; 2023 Feb; 614(7946):41-42. PubMed ID: 36650387
    [No Abstract]   [Full Text] [Related]  

  • 74. Success in Life: With a Personal Application.
    Towner A
    Bistoury; 1878 Jul; 14(2):35-38. PubMed ID: 37054312
    [No Abstract]   [Full Text] [Related]  

  • 75. How should good lung health be defined at the population and individual levels?
    Soriano JB; Jenkins C
    Eur Respir J; 2023 Sep; 62(3):. PubMed ID: 37690786
    [No Abstract]   [Full Text] [Related]  

  • 76. Success in Life.
    Halls J Health; 1878 Jul; 25(7):520-521. PubMed ID: 36488749
    [No Abstract]   [Full Text] [Related]  

  • 77. Success in Life.
    Halls J Health; 1880 Jul; 27(7):207-208. PubMed ID: 36489421
    [No Abstract]   [Full Text] [Related]  

  • 78. Success in Life.
    Halls J Health; 1882 Aug; 29(8):431-432. PubMed ID: 36490628
    [No Abstract]   [Full Text] [Related]  

  • 79. Success in Life.
    Halls J Health; 1871 Aug; 18(8):181-182. PubMed ID: 36487071
    [No Abstract]   [Full Text] [Related]  

  • 80. A qualitative study of interactions with oncologists among patients with advanced lung cancer.
    Al Achkar M; Basu Roy U; Manley E; Standifer M; Baik C; Walsh CA
    Support Care Cancer; 2022 Nov; 30(11):9049-9055. PubMed ID: 35948849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.